Atlas Trials

Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants

Clinical trial NCT00138060 · COMPLETED

Trial details

NCT number
NCT00138060
Sponsor
Institut de Recherche Clinique sur les Cancers et le Sang
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2005-06-01
Primary completion
2008-11-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.